Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough



Rating:

Share or cite this content

Citations should be made in the following way:
M. Kere (Stockholm, Sweden), S. Björkander (Stockholm, Sweden), S. Klevebro (Stockholm, Sweden), M. Ödling (Stockholm, Sweden), S. Ekström (Stockholm, Sweden), I. Mogensen (Stockholm, Sweden), M. Van Hage (Stockholm, Sweden), A. Bergström (Stockholm, Sweden), I. Kull (Stockholm, Sweden), E. Melén (Stockholm, Sweden). Clinical variables and protein biomarkers associated with blood eosinophil count and asthma in young adults. 3122

Member's Comments

No comment yet.

Related content which might interest you: Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA) Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020 Clinical significance of blood neutrophil differential count in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 The blood eosinophil count as a biomarker in COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015 Blood eosinophil count as a predictor of treatment response in adult patients with chronic cough Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020 Blood eosinophil counts and degree of allergen sensitization as age dependent correlations in children with asthma Source: Eur Respir J 2001; 18: Suppl. 33, 452s Year: 2001 Associations between blood eosinophils and decline in lung function among adults with and without asthma Source: Eur Respir J, 51 (4) 1702536; 10.1183/13993003.02536-2017 Year: 2018 Association between blood eosinophil count and risk of exacerbations in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Association between blood eosinophil counts and risk of rehospitalization in patients with asthma Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017 Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease Source: Eur Respir J 2016; 47:1299-1303 Year: 2016 Blood eosinophil count and exacerbation risk in patients with COPD Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017 Year: 2017 Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Correlations between exacerbation rate and blood eosinophil levels in COPD patients Source: International Congress 2017 – Infection and exacerbation science Year: 2017 BAL eosinophil counts and specific clinical phenotypes of asthmatic and/or atopic children Source: Annual Congress 2011 - Flexible bronchoscopy in the diagnosis of paediatric lung diseases Year: 2011 Relationship between blood eosinophil count (Eos), clinical characteristics and mortality of patients with COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 FENO and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Relationship between blood eosinophil levels and severity of COPD Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Determinants of blood eosinophil count in adults from a large population-based study Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD Source: Eur Respir J, 51 (5) 1800120; 10.1183/13993003.00120-2018 Year: 2018 Mepolizumab does not alter blood basophil count in severe asthma Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019 Is blood eosinophil count a biomarker for chronic obstructive pulmonary disease in a real-world clinical setting? Predictive property and longitudinal stability in Japanese patients. Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases Year: 2021